Literature DB >> 31244974

Cerebellar Ataxia With Extreme Photophobia Associated With Anti-SOX1 Antibodies.

Lucas Alessandro1, Daniel Schachter2, Mauricio F Farez3,4, Francisco Varela1.   

Abstract

Anti-SOX1 antibodies are associated with diverse neurological syndromes, targeting both the central (paraneoplastic cerebellar degeneration) and peripheral nervous systems (Lambert Eaton myasthenic syndrome, paraneoplastic neuropathy). Although the pathogenic role of these antibodies remains unclear, their strong association with underlying neoplastic disease (mainly small-cell lung cancer) has designated them as onconeural antibodies. Here, we present a case of cerebellar ataxia with marked photophobia, with severe atrophy of the cerebellum and brain stem, associated with anti-SOX1 antibodies without evidence of an underlying malignancy. Although anti-SOX1-associated cerebellar syndrome is infrequent, investigation of these antibodies should be considered as a part of the diagnostic algorithm if more common causes have been ruled out. Extensive brain stem lesions causing disruption of the trigeminal pathway and its connections with the pretectal area might explain the underlying mechanism of the associated photophobia. Early recognition of anti-SOX1 antibodies, exclusion of underlying neoplasm, and prompt initiation of immunotherapy are essential to achieve a better outcome.

Entities:  

Keywords:  SOX1 protein; cerebellar ataxia; paraneoplastic cerebellar degeneration

Year:  2018        PMID: 31244974      PMCID: PMC6582382          DOI: 10.1177/1941874418802130

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  16 in total

Review 1.  From head to toes: the multiple facets of Sox proteins.

Authors:  M Wegner
Journal:  Nucleic Acids Res       Date:  1999-03-15       Impact factor: 16.971

2.  Expression of Sox1, Sox2 and Sox9 is maintained in adult human cerebellar cortex.

Authors:  Joelle Alcock; James Lowe; Tim England; Philip Bath; Virginie Sottile
Journal:  Neurosci Lett       Date:  2008-11-27       Impact factor: 3.046

3.  Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.

Authors:  M Tschernatsch; P Singh; O Gross; T Gerriets; N Kneifel; C Probst; S Malas; M Kaps; F Blaes
Journal:  J Neuroimmunol       Date:  2010-08-11       Impact factor: 3.478

4.  Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

Authors:  F Keime-Guibert; F Graus; A Fleury; R René; J Honnorat; P Broet; J Y Delattre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

5.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 6.  Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy.

Authors:  Raymond Voltz
Journal:  Lancet Neurol       Date:  2002-09       Impact factor: 44.182

7.  SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.

Authors:  L Sabater; M Titulaer; A Saiz; J Verschuuren; A O Güre; F Graus
Journal:  Neurology       Date:  2007-11-21       Impact factor: 9.910

8.  Cerebellar ataxia as a possible organ-specific autoimmune disease.

Authors:  Marios Hadjivassiliou; Sabrina Boscolo; Enrico Tongiorgi; Richard A Grünewald; Basil Sharrack; David S Sanders; Nicola Woodroofe; G Aelwyn B Davies-Jones
Journal:  Mov Disord       Date:  2008-07-30       Impact factor: 10.338

9.  Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study.

Authors:  U Nath; Y Ben-Shlomo; R G Thomson; A J Lees; D J Burn
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

Review 10.  Antibodies and neuronal autoimmune disorders of the CNS.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  J Neurol       Date:  2009-12-25       Impact factor: 4.849

View more
  2 in total

1.  Coexistence of Anti-SOX1 and Anti-GABAB Receptor Antibodies with Autoimmune Encephalitis in Small Cell Lung Cancer: A Case Report.

Authors:  Wei Qin; Xiao Wang; Jing Yang; Wenli Hu
Journal:  Clin Interv Aging       Date:  2020-02-07       Impact factor: 4.458

2.  Coexistence of anti-SOX1 and anti-GABAB receptor antibodies with paraneoplastic limbic encephalitis presenting with seizures and memory impairment in small cell lung cancer: A case report.

Authors:  Sizhu Gong; Yue Han; Enling He; Min Liu; Xiyao Fu; Fang Deng
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.